The Menopause Transition // Age 35-55
Predictive Intelligence
for High-Performing Women.
Don't just track your symptoms—engineer your biology.
We forecast your capacity, vet every recommendation for safety, and prescribe the exact protocol to keep you performing.
The $150B Metabolic Blindspot.
Perimenopause is not a lifestyle transition. It is a systemic neuro-endocrine failure that drives high-achieving women out of the workforce at the peak of their careers.
Annual Economic Drain
The global economy loses $150 billion annually due to menopause-related productivity losses and absenteeism. It is the most expensive, unaddressed biological crisis in the modern workforce.
Experience Symptoms
Despite the vast majority of women experiencing severe neuro-endocrine symptoms, standard of care still relies on outdated lifestyle advice over clinical intervention.
Exit the Workforce
Over 1 in 10 women quit their jobs due to unmanaged symptoms, and 20% consider early retirement.
Wage Penalty
Women experiencing severe symptoms earn 10% less four years later due to reduced hours and lost promotions.
U.S. Productivity Loss
Annual loss in the United States alone from missed work days and menopause-related medical expenses.
Sources: Mayo Clinic Proceedings (2023) | Stanford University Economic Impact Study (2024) | SHRM Menopause in the Workplace Report (2023)
Engineered for the
High-Performance Phenotype.
Designed for the executive who cannot afford biological volatility. If you demand clinical rigor over 'wellness advice,' The New Spring is your operating system.
The Architecture
Closed-Loop Neuro-Endocrine Regulation.
Predictive Intelligence
Anticipates biological volatility before it happens.
Clinical Safety Firewall
ISO 13485-compliant contraindication checks.
Bio-Regional Protocols
Exogenous inputs to mitigate physiological load.
The Only Clinical-Grade Solution.
| Capability | Period Trackers (Clue/Flo) | Wearables (Oura/Apple) | The New Spring |
|---|---|---|---|
| Data Architecture | Manual Input | Raw Sensor Telemetry | Neuro-Symbolic Ingest |
| Time Horizon | Retroactive (Past) | Descriptive (Present) | Predictive (Future) |
| Clinical Safety | None | Standard Wellness | ISO 13485 Safety Firewall |
| User Outcome | Awareness | Data Visualization | Risk Mitigation |
Affron®
Standardized Extract
The Shop
Clinical-Grade
Protocol Fulfillment.
Direct integration of evidence-backed botanical interventions (e.g., Standardized Saffron). We treat the mechanism, not just the symptom.
Fulfilled directly in-app.
Clinical Logic
"Targeting HPA Axis dysregulation requires precise dosing. Generic supplements lack the bioavailability required for neuro-endocrine intervention."
"Current algorithms lack clinical context. We provide the signal in the noise."
Sarla Singh
Systems Architect // The New Spring
How We're Different
We built this for women who don't settle for generic solutions. Here's what makes The New Spring the operating system for your Second Spring.